Vivos therapeutics announces pricing of $21m initial public offering

Highlands ranch, colo., dec. 10, 2020 (globe newswire) -- vivos therapeutics, inc. (“ vivos ”), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, today announced the pricing of its initial public offering of 3,500,000 shares of its common stock at a public offering price of $6.00 per share. the shares of common stock are expected to begin trading on the nasdaq capital market under the ticker symbol “vvos” on friday, december 11, 2020.
VVOS Ratings Summary
VVOS Quant Ranking